BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21079196)

  • 1. Proteomic analysis of peritoneal fluid of patients treated by peritoneal dialysis: effect of glucose concentration.
    Cuccurullo M; Evangelista C; Vilasi A; Simeoni M; Avella F; Riccio E; Memoli B; Malorni A; Capasso G
    Nephrol Dial Transplant; 2011 Jun; 26(6):1990-9. PubMed ID: 21079196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis of peritoneal dialysate fluid in patients with different types of peritoneal membranes.
    Sritippayawan S; Chiangjong W; Semangoen T; Aiyasanon N; Jaetanawanitch P; Sinchaikul S; Chen ST; Vasuvattakul S; Thongboonkerd V
    J Proteome Res; 2007 Nov; 6(11):4356-62. PubMed ID: 17924681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term increase of glucose concentration in PDS results in extensive removal and high glycation level of vital proteins during continuous ambulatory peritoneal dialysis.
    Pešić I; Dihazi GH; Müller GA; Jahn O; Hoffmann M; Eltoweissy M; Koziolek M; Dihazi H
    Nephrol Dial Transplant; 2011 Aug; 26(8):2674-83. PubMed ID: 21285129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis in peritoneal dialysis patients with different peritoneal transport characteristics.
    Wen Q; Zhang L; Mao HP; Tang XQ; Rong R; Fan JJ; Yu XQ
    Biochem Biophys Res Commun; 2013 Aug; 438(3):473-8. PubMed ID: 23916703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic profiling and identification in peritoneal fluid of children treated by peritoneal dialysis.
    Raaijmakers R; Pluk W; Schröder CH; Gloerich J; Cornelissen EA; Wessels HJ; Willems JL; Monnens LA; van den Heuvel LP
    Nephrol Dial Transplant; 2008 Jul; 23(7):2402-5. PubMed ID: 18424818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential proteomic characterization between normal peritoneal fluid and diabetic peritoneal dialysate.
    Wang HY; Tian YF; Chien CC; Kan WC; Liao PC; Wu HY; Su SB; Lin CY
    Nephrol Dial Transplant; 2010 Jun; 25(6):1955-63. PubMed ID: 20054029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative proteomics analysis of peritoneal dialysate before and after the occurrence of peritonitis episode by mass spectrometry.
    Tyan YC; Su SB; Ting SS; Wang HY; Liao PC
    Clin Chim Acta; 2013 May; 420():34-44. PubMed ID: 23078846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
    Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis of peritoneal dialysate fluid in patients with dialysis-related peritonitis.
    Lin WT; Tsai CC; Chen CY; Lee WJ; Su CC; Wu YJ
    Ren Fail; 2008; 30(8):772-7. PubMed ID: 18791950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline peritoneal solute transport rate is not associated with markers of systemic inflammation or comorbidity in incident Korean peritoneal dialysis patients.
    Oh KH; Moon JY; Oh J; Kim SG; Hwang YH; Kim S; Lee JS; Ahn C
    Nephrol Dial Transplant; 2008 Jul; 23(7):2356-64. PubMed ID: 18178604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solutes transport characteristics in peritoneal dialysis: variations in glucose and insulin serum levels.
    da Silva DR; Figueiredo AE; Antonello IC; Poli de Figueiredo CE; d'Avila DO
    Ren Fail; 2008; 30(2):175-9. PubMed ID: 18300117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis--a multicentre study in Japan.
    Hirahara I; Inoue M; Okuda K; Ando Y; Muto S; Kusano E
    Nephrol Dial Transplant; 2007 Feb; 22(2):560-7. PubMed ID: 17035369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transport of peritoneal membrane assessed before and after the start of peritoneal dialysis.
    La Milia V; Limardo M; Cavalli A; Crepaldi M; Locatelli F
    Nephrol Dial Transplant; 2009 Sep; 24(9):2894-8. PubMed ID: 19349295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of systemic and local peritoneal inflammation on peritoneal solute transport rate in new peritoneal dialysis patients: a 1-year prospective study.
    Cho JH; Hur IK; Kim CD; Park SH; Ryu HM; Yook JM; Choi JY; Choi HJ; Choi HJ; Park JW; Do JY; Kim YL
    Nephrol Dial Transplant; 2010 Jun; 25(6):1964-73. PubMed ID: 20100731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase levels in the drained dialysate reflect the peritoneal solute transport rate: a multicentre study in Japan.
    Hirahara I; Inoue M; Umino T; Saito O; Muto S; Kusano E
    Nephrol Dial Transplant; 2011 May; 26(5):1695-701. PubMed ID: 20921293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling of myelin proteins by 2D-gel electrophoresis and multidimensional liquid chromatography coupled to MALDI TOF-TOF mass spectrometry.
    Vanrobaeys F; Van Coster R; Dhondt G; Devreese B; Van Beeumen J
    J Proteome Res; 2005; 4(6):2283-93. PubMed ID: 16335977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.
    Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J
    J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of peritoneal fluid in women with endometriosis.
    Ferrero S; Gillott DJ; Remorgida V; Anserini P; Leung KY; Ragni N; Grudzinskas JG
    J Proteome Res; 2007 Sep; 6(9):3402-11. PubMed ID: 17676783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of new dialysis solutions on clinical results in patients treated with peritoneal dialysis].
    Haag-Weber M
    Wien Klin Wochenschr; 2005; 117 Suppl 6():89-97. PubMed ID: 16437339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A proteomic view on the role of glucose in peritoneal dialysis.
    Lechner M; Kratochwill K; Lichtenauer A; Rehulka P; Mayer B; Aufricht C; Rizzi A
    J Proteome Res; 2010 May; 9(5):2472-9. PubMed ID: 20334435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.